Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
4.675
+0.025 (0.54%)
Dec 20, 2024, 2:43 PM EST - Market open
Journey Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Journey Medical stock have an average target of 9.50, with a low estimate of 8.50 and a high estimate of 11. The average target predicts an increase of 103.21% from the current stock price of 4.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 6, 2024.
Analyst Ratings
The average analyst rating for DERM stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +92.51% | Sep 6, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +135.29% | Jun 28, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +81.82% | Feb 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +28.34% | Sep 7, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | +28.34% | Jul 12, 2023 |
Financial Forecast
Revenue This Year
57.86M
from 79.18M
Decreased by -26.93%
Revenue Next Year
78.97M
from 57.86M
Increased by 36.49%
EPS This Year
-1.02
from -0.21
EPS Next Year
-0.09
from -1.02
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 60.2M | 86.8M | 98.1M |
| Avg | 57.9M | 79.0M | 95.3M |
| Low | 54.7M | 70.3M | 91.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -24.0% | 50.1% | 24.2% |
| Avg | -26.9% | 36.5% | 20.7% |
| Low | -31.0% | 21.5% | 15.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.00 | 0.16 | -0.05 |
| Avg | -1.02 | -0.09 | -0.05 |
| Low | -1.02 | -0.60 | -0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.